|
|
||||||||
CASE STUDY |
|
Department of Surgery 1 Department of Internal Medicine 2 Department of Laboratory Far Eastern Memorial Hospital Taipei, Taiwan |
| For reprint information contact: Kok Va Kei, MD Tel: 886 2 2351 1176 Fax: 886 2 2883 2699 email: kokvakei{at}ms29.hinet.net 5th Floor No. 17, Lane 12, Chin-Tien Street, Taipei 106, Taiwan, ROC. |
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
| Case Report |
|---|
|
|
|---|
|
|
|
| Discussion |
|---|
|
|
|---|
Echocardiography can indicate patients at risk of Candida pericarditis; positive culture for Candida in pericardial fluid or histologic evidence of yeast in pericardial tissue establishes the diagnosis. Therapeutic intervention should consist of adequate drainage and systemic antifungal treatment. Although amphotericin B was used in earlier reports, it has poor pericardial penetration.8 Fluconazole is less toxic and may be more effective than amphotericin B for Candida pericarditis. An intravenous fluconazole dosage of 800 mg per day may be considered as primary therapy for hematogenous candidiasis.5 The dosage may be decreased to 400 mg per day and given orally, depending on the rapidity of the response. The optimal duration of effective therapy for candidemia is not well-defined and ranges from 15 to 33 days.5 All patients whose diagnosis was overlooked, died of their disease, whereas patients who were diagnosed and treated survived for a mean follow-up of 19 months, with no signs of infection.4 Our patient survived after combined antifungal therapy and surgical intervention. This experience indicates that the thoracic cavity can be contaminated by a primary stab injury and inadequate drainage can make further infection likely.
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |